Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders

Summary

This is an open-label extension protocol that will provide necessary data on the safety, tolerability, pharmacokinetics and efficacy of STX209 among subjects with ASD.

Timeline

Start

2011-11

Primary completion

2013-07

Completion

2013-07

Drugs

Indications